Alzheimer's beginnings prove to be a sticky situation

by Layne Cameron , Lisa Lapidus,Michigan State UniversityMSU's Lisa Lapidus uses lasers to reveal a common trait of Alzheimer's beginnings. Credit: G.L. KohuthLaser technology has reveal

Updated on: April 18,2024

Alzheimer's beginnings prove to be a sticky situation

by Layne Cameron , Lisa Lapidus,Michigan State UniversityMSU's Lisa Lapidus uses lasers to reveal a common trait of Alzheimer's beginnings. Credit: G.L. KohuthLaser technology has reveal

Updated on:April 18,2024

A novel immunotherapy proves effective in animal models of multiple sclerosis

by Thomas Jefferson UniversityThe purified oligodendrocyte extracellular vesicles under an electron microscope. Credit: G. Casella et al., Science Translational Medicine (2020)Multiple sclerosis

Updated on: March 25,2024

A novel immunotherapy proves effective in animal models of multiple sclerosis

by Thomas Jefferson UniversityThe purified oligodendrocyte extracellular vesicles under an electron microscope. Credit: G. Casella et al., Science Translational Medicine (2020)Multiple sclerosis

Updated on:March 25,2024

Deaths from Alzheimer's disease in Scotland increase by 33.4% in one year

by Alzheimer's Research UKDeaths from Alzheimer's in Scotland have soared by 33.4 percent in a year, according to new statistics released by the National Records of Scotland today.Provisi

Updated on: March 07,2024

Deaths from Alzheimer's disease in Scotland increase by 33.4% in one year

by Alzheimer's Research UKDeaths from Alzheimer's in Scotland have soared by 33.4 percent in a year, according to new statistics released by the National Records of Scotland today.Provisi

Updated on:March 07,2024

Understanding the role of microglia in Alzheimer's disease

by VIB (the Flanders Institute for Biotechnology)Illustration of the complex microglial AD genetics by cell-state profiles and driven by different Aβ pathologies. Credit:Nature Neuroscience

Updated on: March 30,2024

Understanding the role of microglia in Alzheimer's disease

by VIB (the Flanders Institute for Biotechnology)Illustration of the complex microglial AD genetics by cell-state profiles and driven by different Aβ pathologies. Credit:Nature Neuroscience

Updated on:March 30,2024

Alzheimer's trial screening data links high amyloid levels with early stage disease

by National Institutes of HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainThe first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer&#39

Updated on: April 20,2024

Alzheimer's trial screening data links high amyloid levels with early stage disease

by National Institutes of HealthPET scan of a human brain with Alzheimer's disease. Credit: public domainThe first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer&#39

Updated on:April 20,2024

Researchers report on the effectiveness of skin biopsy to detect Parkinson's and related neurodegenerative diseases

byBeth Israel Deaconess Medical CenterCredit: Pixabay/CC0 Public DomainIn a paper published in theJournal of the American Medical Association(JAMA), neurologists at Beth Israel Deaco

Updated on: March 28,2024

Researchers report on the effectiveness of skin biopsy to detect Parkinson's and related neurodegenerative diseases

byBeth Israel Deaconess Medical CenterCredit: Pixabay/CC0 Public DomainIn a paper published in theJournal of the American Medical Association(JAMA), neurologists at Beth Israel Deaco

Updated on:March 28,2024

Genetic 'hotspots' that speed up and slow down brain aging could provide new targets for Alzheimer's drugs

by University of Southern CaliforniaCredit: CC0 Public DomainResearchers from a USC-led consortium have discovered 15 "hotspots" in the genome that either speed up brain aging or slow i

Updated on: June 20,2024

Genetic 'hotspots' that speed up and slow down brain aging could provide new targets for Alzheimer's drugs

by University of Southern CaliforniaCredit: CC0 Public DomainResearchers from a USC-led consortium have discovered 15 "hotspots" in the genome that either speed up brain aging or slow i

Updated on:June 20,2024

Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

by Mayo ClinicDementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzhei

Updated on: March 07,2024

Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

by Mayo ClinicDementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzhei

Updated on:March 07,2024

More than just neurons: Scientists create new model for studying human brain inflammation

bySalk InstituteHuman astrocytes (green) extending processes that wrap around the host blood vessel (magenta). Credit: Salk InstituteThe brain is typically depicted as a complex web of neurons s

Updated on: March 13,2024

More than just neurons: Scientists create new model for studying human brain inflammation

bySalk InstituteHuman astrocytes (green) extending processes that wrap around the host blood vessel (magenta). Credit: Salk InstituteThe brain is typically depicted as a complex web of neurons s

Updated on:March 13,2024

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,

Updated on: June 07,2024

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,

Updated on:June 07,2024

Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

by Bentham Science PublishersNicotinic acetylcholine receptors (nAChRs) have been pursued for decades as potential molecular targets to treat cognitive dysfunction in Alzheimer's disease (AD) due

Updated on: March 07,2024

Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

by Bentham Science PublishersNicotinic acetylcholine receptors (nAChRs) have been pursued for decades as potential molecular targets to treat cognitive dysfunction in Alzheimer's disease (AD) due

Updated on:March 07,2024

Researchers find preclinical evidence that a nasal immunotherapy may help treat Alzheimer's disease

by Brigham and Women's HospitalCredit: Unsplash/CC0 Public DomainAlzheimer's is a debilitating neurodegenerative and neuroinflammatory disease that is difficult to treat. Most existing th

Updated on: March 02,2024

Researchers find preclinical evidence that a nasal immunotherapy may help treat Alzheimer's disease

by Brigham and Women's HospitalCredit: Unsplash/CC0 Public DomainAlzheimer's is a debilitating neurodegenerative and neuroinflammatory disease that is difficult to treat. Most existing th

Updated on:March 02,2024